Inductive Bio
A role at Inductive Bio focused on accelerating drug discovery through AI-powered platform development and collaboration with scientific and technical teams.
Company Size
1-10 employees
Inductive Bio is an AI-powered virtual lab for drug discovery, helping pharmaceutical and biotech teams evaluate and optimize small molecule candidates faster. Their platform includes Beacon-1 ADMET models (ranked first in multiple global blind ADMET benchmarks), Compass software for running virtual experiments, and Indy, an AI chemistry assistant that automates time-consuming operations. Backed by a pre-competitive industry data consortium and embedded expert services, Inductive Bio enables end-to-end AI-informed design-make-test cycles to accelerate development candidates.
Inductive Bio Raises $25M Series A to Transform Small Molecule Drug Discovery with Industry-Wide AI Platform
May 7, 2025
Inductive Bio gains $21m ARPA-H funds for drug prediction models
Dec 9, 2025
Fixing drug discovery’s most persistent problem with AI
Jul 10, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Inductive Bio.
Inductive Bio didn’t post a salary, so this is our estimate from similar listings.
Novel AI Drug Toxicity Models to Improve Drug Safety to Be Developed by an Industrial-Academic Group
Dec 10, 2025
Associate Director/Director Medicinal Chemistry
Relation Therapeutics
Senior Director, AIRx Discovery Biology Lead
Takeda Pharmaceutical Company Limited
Associate Director, Synthetic Chemistry
Transitionbio
Head of Computational Drug Design, Cambridge, MA
Isomorphic Labs
Principal Scientist, Discovery Chemistry
Bristol Myers Squibb
Product Management Intern
Enveda